RANCHO CORDOVA, Calif.,
Jan. 11, 2022 /PRNewswire/
-- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), today
announced that the Company's 2021 Annual Meeting of Stockholders
(the "Annual Meeting") will reconvene on Thursday, January 13, 2022 at 12:00 p.m. EST. The meeting, originally scheduled
for December 16, 2021, was convened
and adjourned without any business being conducted due to lack of
the required quorum.
The Annual Meeting will be held at the Company's corporate
headquarters, located at 2711 Citrus Rd., Rancho Cordova, CA 95742. A conference call
and webcast will be available for those who wish to participate. To
join in the conference call, please dial
1-844-889-4331 (domestic), 1-412-380-7406 (international)
or 1-866-605-3852 (Canada).
To access a live webcast of the call, please
visit: https://thermogenesis.com/investors/news-and-events/events-webcasts.
Only stockholders of record as of the record date, October 26, 2021, are entitled to and are being
requested to vote. At the time the Annual Meeting was adjourned,
proxies had been submitted by stockholders representing
approximately 49.39% of the shares of the Company's common stock
outstanding and entitled to vote at the Annual Meeting. Proxies
previously submitted in respect of the Annual Meeting that were
submitted prior to the adjourned Annual Meeting will be voted at
the rescheduled Annual Meeting unless they had been properly
revoked.
The Company encourages all stockholders of record on
October 26, 2021, who have not yet
voted, to do so by tomorrow, January 12,
2022. Stockholders who have any questions or require any
assistance with completing a proxy or voting instruction form or
who do not have the required materials may contact the Company at
(916) 858-5100 or by emailing ir@thermogenesis.com.
Important Information
This material may be deemed to
be solicitation material in respect of the Annual Meeting to be
reconvened on January 13, 2022. In
connection with the Annual Meeting, the Company filed the Proxy
Statement. BEFORE MAKING ANY VOTING DECISIONS, SECURITY HOLDERS ARE
URGED TO READ THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS
FILED WITH THE SEC, BECAUSE THEY CONTAIN IMPORTANT INFORMATION
ABOUT THE ANNUAL MEETING. No changes have been made in the
proposals to be voted on by stockholders at the Annual Meeting. The
Company's Proxy Statement and any other materials filed by the
Company with the SEC can be obtained free of charge at the SEC's
website at sec.gov or the Company's website at
thermogenesis.com.
About ThermoGenesis Holdings, Inc.
ThermoGenesis
Holdings, Inc. develops, commercializes, and markets a range of
automated technologies for CAR-T and other cell-based therapies.
The Company currently markets a full suite of solutions for
automated clinical biobanking, point-of-care applications, and
automation for immuno-oncology, including its semi-automated,
functionally-closed CAR-TXpress™ platform, which streamlines
the manufacturing process for the emerging CAR-T immunotherapy
market. For more information about ThermoGenesis, please
visit: www.thermogenesis.com.
Company Contact:
Wendy
Samford
916-858-5191
ir@ThermoGenesis.com
Investor Contact:
Paula Schwartz, Rx
Communications
917-322-2216
pschwartz@rxir.com
View original
content:https://www.prnewswire.com/news-releases/thermogenesis-holdings-to-hold-reconvened-annual-meeting-of-stockholders-on-january-13-2022-301458410.html
SOURCE ThermoGenesis Holdings, Inc.